Health CanadaGeneral Alert
SGLT2 Inhibitors [INVOKANA (canagliflozin), FORXIGA (dapagliflozin), XIGDUO (dap...
Published: May 16, 2016Recall ID: 55483Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
SGLT2 Inhibitors [INVOKANA (canagliflozin), FORXIGA (dapagliflozin), XIGDUO (dapagliflozin/metformin), JARDIANCE (empagliflozin)] - Risk of Diabetic Ketoacidosis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 55483 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/sglt2-inhibitors-invokana-canagliflozin-forxiga-dapagliflozin-xigduo |
| Issue | Product safety |
| Title | SGLT2 Inhibitors [INVOKANA (canagliflozin), FORXIGA (dapagliflozin), XIGDUO (dapagliflozin/metformin), JARDIANCE (empagliflozin)] - Risk of Diabetic Ketoacidosis |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2016-05-16 |
| Organization | Marketed health products |